Business / Finance RSS Feed - Business / Finance

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal. [More]
Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

Astute Medical to get $30 million from CRG to support commercialization of NephroCheck Test System

Astute Medical, Inc. and CRG today announced that Astute recently achieved a milestone under the terms of its existing term loan agreement with CRG. Under the term loan agreement, CRG will provide up to $30 million to support the commercialization of the NephroCheck Test System. [More]
Isis Pharmaceuticals secures $18 million from GSK to advance ISIS-TTR Rx Phase 2/3 study

Isis Pharmaceuticals secures $18 million from GSK to advance ISIS-TTR Rx Phase 2/3 study

Isis Pharmaceuticals, Inc. announced today that it has earned an $18 million milestone payment from GlaxoSmithKline related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy (FAP). [More]
Endo International enters into definitive agreement to acquire Auxilium Pharmaceuticals

Endo International enters into definitive agreement to acquire Auxilium Pharmaceuticals

Endo International plc and Auxilium Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Endo will acquire all of the outstanding shares of common stock of Auxilium for a per share consideration of $33.25 in a cash and stock transaction. [More]
Impax executes definitive agreement to acquire Tower Holdings, Lineage Therapeutics

Impax executes definitive agreement to acquire Tower Holdings, Lineage Therapeutics

Impax Laboratories, Inc. today announced the execution of a definitive agreement under which Impax will acquire Tower Holdings, Inc., including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, and Lineage Therapeutics Inc. (together, the "Companies") for $700 million in cash, subject to certain customary purchase price adjustments. [More]
Porvair Sciences appoints SPEware Corporation as its exclusive partner

Porvair Sciences appoints SPEware Corporation as its exclusive partner

Porvair Sciences, a world leader in applications optimised microplates and microplate equipment has appointed SPEware Corporation (Baldwin Park, CA) as its exclusive partner for supporting and servicing its UltraVap, MiniVap and UltraVap Mistral microplate sample concentration systems. [More]

HIMSS, AVIA announce new initiative to co-develop HX360 to improve health care delivery

Today, Healthcare Information and Management Systems Society and AVIA announced HX360, a new co-developed initiative. HX360 was created to improve the way that health care is delivered by both inspiring and facilitating the adoption and use of next generation (non-EHR Platform) technologies by provider organizations, in areas where health system executives are passionate to combine the right mix of resources, processes and technologies. [More]

Digital Clinic International acquired by Voice Solutions

As the digital signage industry continues to gain momentum, Voice Solutions announced that it has acquired Digital Clinic International LLC, a digital signage company focused on the needs of dental, cosmetic surgery and health care clinics. [More]
PointRight announces phased strategic partnership with Prime Care Technologies

PointRight announces phased strategic partnership with Prime Care Technologies

PointRight, the industry-standard predictive analytics leader and Prime Care Technologies, the post-acute industry's leading provider of technology-enabled business solutions, announce a phased strategic partnership whereby the industry-standard PointRight® Pro 30™ rehospitalization measure will be incorporated into primeVIEW, Prime Care Technology's business intelligence solution. [More]
CSL Behring strengthens global manufacturing capabilities to meet demand for lifesaving therapies

CSL Behring strengthens global manufacturing capabilities to meet demand for lifesaving therapies

CSL Behring today announced a multi-year, $450 million two-site global capacity expansion – the latest in a series of recent production expansions to meet the growing need for its lifesaving and life-improving therapies that are used to treat patients with rare and serious medical disorders around the world. [More]
Gerresheimer Q3 revenues up 2.2% to EUR 323.9m

Gerresheimer Q3 revenues up 2.2% to EUR 323.9m

Gerresheimer AG again increased revenues in the third quarter of financial year 2014. [More]
GenomOncology, med fusion partner to optimize treatment strategies for tumor

GenomOncology, med fusion partner to optimize treatment strategies for tumor

med fusion, an integrated molecular center of excellence and clinical trials service organization and GenomOncology, an Ohio based genomics technology and services provider, today announced a partnership to optimize treatment strategies based on the patient's disease state and tumor profile. [More]
C3BS inks preferred access agreement with Mayo Clinic

C3BS inks preferred access agreement with Mayo Clinic

Cardio3 BioSciences, a leader in the discovery, development and commercialization of regenerative, protective and reconstructive therapies, announces today the signing of a preferred access agreement with Mayo Clinic. [More]

Global Village Consulting renamed as Gevity Consulting

Global Village Consulting (Canada) announced today, effective immediately, it will operate under the name Gevity Consulting Inc. At the same time, the company unveiled a new logo and visual brand identity. [More]
VHA enters into agreement with Jefferson School of Population Health

VHA enters into agreement with Jefferson School of Population Health

VHA Inc., the national health care network, has entered into an agreement with the Jefferson School of Population Health to jointly create, market and present professional development programs and conferences on population health, governance and other related healthcare transformation topics. [More]
DSM Venturing invests in ZeaVision Holdings

DSM Venturing invests in ZeaVision Holdings

ZeaVision Holdings, Inc., maker of the EyePromise® brand of doctor-recommended nutraceuticals, has received an equity investment from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company. [More]
New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies

New England Biolabs inks deal to supply critical reagents to TriLink BioTechnologies

New England Biolabs, Inc. (NEB®) has strengthened its position as a key supplier to the fast-growing RNA synthesis market by signing an agreement to supply critical reagents to TriLink BioTechnologies, Inc., a leading manufacturer of mRNA and long RNA for research, diagnostic and therapeutic applications. [More]
Achieve Nutrition Systems, Game Plan Holdings announce new partnership deal

Achieve Nutrition Systems, Game Plan Holdings announce new partnership deal

Game Plan Holdings, Inc., a nutritional supplements company that distributes products both online and through a network of fitness professionals, announced today it entered a partnership deal with Achieve Nutrition Systems, a one-of-a-kind company serving businesses in the fitness, nutrition and therapeutic industries by offering a professional development network with revenue streams, systems and coaching to business owners who want to take their business and professionalism the next level. [More]

NorthStar Healthcare invests over $170M In two healthcare real estate transactions

NorthStar Healthcare Income, Inc. (NorthStar Healthcare) announced that it recently invested more than $170.0 million in two healthcare real estate transactions, including one assisted living portfolio acquisition and one mezzanine loan backed by a portfolio of skilled nursing and assisted living facilities. [More]
Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Avidity NanoMedicines today announced that it has expanded its investor syndicate through the closing of a $6 million convertible note financing co-led by Fidelity Biosciences and TPG Biotech. [More]